As a global leader in generic and vaccine production, India’s Pharma, Healthcare, and Life Sciences sector is now pivoting towards advanced capabilities in research and development (R&D), biosimilars, and digital health. Government initiatives (like Ayushman Bharat) and technology (telemedicine) are rapidly expanding healthcare access and driving innovation across the entire value chain, from drug discovery to patient care. The opportunity lies in strengthening this ecosystem, which requires highly specialized talent in clinical trials, complex regulatory affairs, biomanufacturing, and data science applied to accelerated drug development.